PI3KC2 alpha inhibitors (Monash University)

N/A

Report date: 2025/01/26 16:52:12
NME

Base Information

Drug NamePI3KC2 alpha inhibitors (Monash University)
Drug Alias Namephosphoinositide 3-kinase C2 alpha inhibitors (Monash University)MIPS-19416
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha inhibitorsCoagulation factor inhibitors
TargetsCoagulation factorPhosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMonash University
China Registration ClassN/A

Develop Information

Active CompaniesMonash University
Inactive CompaniesN/A
Active IndicationsThrombosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A